News

Resonance Health Files New Provisional Patent

Resonance Health Limited is pleased to announce that it has filed a provisional patent covering the application of novel Antisense Oligonucleotides (ASOs) to treat liver related disease.

Read more

Resonance Health News - April 2020

Resonance Health is delighted to provide you with our latest customer newsletter, where you can find an update on all our latest acitvities.

To read the newsletter please click here

Resonance Health Partners with Siemens Healthineers

Resonance Health is pleased to announce that it has entered into a Solution Partner Agreement with Siemens Healthcare GmbH (Siemens Healthineers), a leading medical technology company headquartered in Erlangen, Germany, for the distribution of the Company’s FerriSmart product through the Siemens Healthineers Digital Marketplace.

Read more

New Artificial Intelligence Tool for Automated Assessment of Liver Fat

Resonance Health is pleased to announce that it has successfully trained a neural network (artificial intelligence, ‘AI’) for the automated assessment of liver fat from MRI data.

Read more

Resonance Health Files Provisional Patent

Resonance Health is pleased to announce that it has filed a provisional patent for the discovery and use of novel blood markers to determine an individual’s iron status.  These blood markers have been identified as part of the Company’s molecular medicine R&D program. 

Read more

International Thalassaemia Day

International Thalassaemia Day is a very special day that commemorates thalassemia patients everywhere.  

Read more